Skip to search.
 FTSE 100 Down 1.12%

Rockwell Medical, Inc. (RMTI)

-NasdaqGM
6.61 Down 0.20(2.94%) 23 Sep 21:00
Prev Close:6.81
Open:6.85
Bid:6.36 x 1000
Ask:6.61 x 500
1y Target Est:6.25
Beta:2.44199
Earnings Date:7 Nov - 11 Nov (Est.)
Day's Range:6.61 - 6.91
52wk Range:5.47 - 13.50
Volume:386,399
Avg Vol (3m):297,439
Market Cap:340.59m
P/E (ttm):N/A
EPS (ttm):-0.37
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for RMTI at this time.

Comparison

Symbol% ChgMkt Cap
RMTIDown 2.94%340.59m

Key Statistics

Forward P/E (1 yr):661.00
P/S (ttm):6.31
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.37
Quarterly EPS Est (Sep-16) :-0.10
Mean Recommendation*:3.2
PEG Ratio (5 yr expected):-0.92

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Rockwell Medical, Inc. operates as an integrated biopharmaceutical company in the United States and internationally. It offers products and services for the treatment of end-stage renal disease, chronic kidney disease, iron deficiency, secondary h... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback